Telemetry Investments’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Telemetry Investments’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$720K	–	78
2020 Q1	$720K	Sell	15,000 -2,100	-12%	-$97.7K	2.51%	11
2019 Q4	$803K	Buy	+17,100	New	+$756K	2.68%	13

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Telemetry Investments's RARX Position: Q2 2020 in Review

Telemetry Investments sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 15,000 shares — an estimated $720K sold.

Telemetry Investments first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $803K in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Telemetry Investments reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Telemetry Investments sold 15,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $720K.
Telemetry Investments first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Telemetry Investments's Ra Pharmaceuticals, Inc. Common Stock position peaked at $803K in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Telemetry Investments's 13F filing for Q2 2020, filed 14 Aug 2020.